WALTHAM, Mass., Jan. 31, 2017 /PRNewswire/ -- Inflexxion, Inc. announced the appointment of Bruno Lempernesse to Chief Executive Officer, effective January 1.
Lempernesse brings to Inflexxion over 20 years of experience in the life science and pharma industries. Prior to joining Inflexxion in September as a Senior Advisor, Lempernesse served as Chief Operating Officer and General Manager for North America at Cegedim, Strategic Data, where he grew the North American business as well as provided strategic direction globally.
"Bruno Lempernesse brings not only outstanding leadership to Inflexxion but also a passion for the business and intelligence around our markets and customers that is unparalleled. We are excited to be welcoming Bruno to the Inflexxion team," said John Regazzi, Chairman at Inflexxion. "Bruno's dynamic vision will accelerate the continuing growth of the company."
"I'm thrilled to be joining Inflexxion to lead the organization and continue our success as a thought leader in pain management, behavioral health, and healthcare data analysis," said Lempernesse. "It's exciting to be a part of an organization with such a breadth of expertise; spanning clinical psychologists, epidemiologists, biostatisticians, research scientists, and technology professionals."
Inflexxion helps healthcare organizations, provider communities, pharmaceutical companies, and regulatory authorities to improve patient care and inform public policy. Through their strategic approach and depth of expertise, Inflexxion analyzes and disseminates health-related data for surveillance, risk management, epidemiological studies, quality improvement, and outcome measurement. Inflexxion's unique data collection includes multiple data streams at the point-of-care, Internet Monitoring technology, and web-surveys with hard to reach populations. For more information visit www.inflexxion.com.
SOURCE Inflexxion, Inc.